[1] Yousefi M,Nosrati R,Salmaninejad A,et al.Organ-specific metastasis of breast cancer:molecular and cellular mechanisms underlying lung metastasis[J].Cell Oncol (Dordr),2018,41(2):123-140.
[2] Huang Y,Jin Q,Su M,et al.Leptin promotes the migration and invasion of breast cancer cells by upregulating ACAT2[J].Cell Oncol (Dordr),2017,40(6):537-547.
[3] Ding L,Ellis MJ,Li S,et al.Genome remodelling in a basal-like breast cancer metastasis and xenograft[J].Nature,2010,464(7291):999-1005.
[4] Paduch R.The role of lymphangiogenesis and angiogenesis in tumor metastasis[J].Cell Oncol (Dordr),2016,39(5):397-410.
[5] Massague J,Obenauf AC.Metastatic colonization by circulating tumour cells[J].Nature,2016,529(7586):298-306.
[6] Lorusso G,Ruegg C.The tumor microenvironment and its contribution to tumor evolution toward metastasis[J].Histochem Cell Biol,2008,130(6):1091-1103.
[7] Hüsemann Y,Geigl JB,Schubert F,et al.Systemic spread is an early step in breast cancer[J].Cancer Cell,2008,13(1):58-68.
[8] Klein CA.Parallel progression of primary tumours and metastases[J].Nat Rev Cancer,2009,9(4):302-312.
[9] Braun S,Vogl FD,Naume B,et al.A pooled analysis of bone marrow micrometastasis in breast cancer[J].N Engl J Med,2005,353(8):793-802.
[10] Slade MJ,Coombes RC.The clinical significance of disseminated tumor cells in breast cancer[J].Nat Clin Pract Oncol,2007,4(1):30-41.
[11] Weil RJ,Palmieri DC,Bronder JL,et al.Breast cancer metastasis to the central nervous system[J].Am J Pathol,2005,167(4):913-920.
[12] Lu X,Kang Y.Organotropism of breast cancer metastasis[J].J Mammary Gland Biol Neoplasia,2007,12(2-3):153-162.
[13] Yadav A,Kumar B,Yu JG,et al.Tumor-associated endothelial cells promote tumor metastasis by chaperoning circulating tumor cells and protecting them from Anoikis[J].PLoS One,2015,10(10):e0141602.
[14] Bockhorn M,Jain RK,Munn LL.Active versus passive mechanisms in metastasis:do cancer cells crawl into vessels,or are they pushed[J]?Lancet Oncol,2007,8(5):444-448.
[15] Padua D,Zhang XH,Wang Q,et al.TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4[J].Cell,2008,133(1):66-77.
[16] Yu PF,Huang Y,AUID-Oho,et al.Downregulation of CXCL12 in mesenchymal stromal cells by TGFbeta promotes breast cancer metastasis[J].Oncogene,2017,36(6):840-849.
[17] Hanahan D,Weinberg RA.Hallmarks of cancer:The next generation[J].Cell,2011,144(5):646-674.
[18] Giles AJ,Reid CM,Evans JD,et al.Activation of hematopoietic stem/progenitor cells promotes immunosuppression within the pre-metastatic niche[J].Cancer Res,2016,76(6):1335-1347.
[19] Jian J,Pang Y,Yan HH,et al.Platelet factor 4 is produced by subsets of myeloid cells in premetastatic lung and inhibits tumor metastasis[J].Oncotarget,2017,8(17):27725-27739.
[20] Kaplan RN,Psaila B,Lyden D.Bone marrow cells in the 'pre-metastatic niche':within bone and beyond[J].Cancer Metastasis Rev,2006,25(4):521-529.
[21] Hiratsuka S,Nakamura K,Iwai S,et al.MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis[J].Cancer Cell,2002,2(4):289-300.
[22] Thiery JP,Acloque H,Huang RY,et al.Epithelial-mesenchymal transitions in development and disease[J].Cell,2009,139(5):871-890.
[23] Zlotnik A,Burkhardt AM,Homey B.Homeostatic chemokine receptors and organ-specific metastasis[J].Nat Rev Immunol,2011,11(9):597-606.
[24] Schwarz MK,Wells TN.New therapeutics that modulate chemokine networks[J].Nat Rev Drug Discov,2002,1(5):347-358.
[25] Rafii S,Lyden D.S100 chemokines mediate bookmarking of premetastatic niches[J].Nat Cell Biol,2006,8(12):1321-1323.
[26] Wang J,Loberg R,Taichman RS.The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis[J].Cancer Metastasis Rev,2006,25(4):573-587.
[27] Erler JT,Bennewith KL,Cox TR,et al.Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche[J].Cancer Cell,2009,15(1):35-44.
[28] Zhuang X,Zhang H,Li X,et al.Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1[J].Nat Cell Biol,2017,19(10):1274-1285.
[29] Blanco MA,Kang Y.Signaling pathways in breast cancer metastasis-novel insights from functional genomics[J].Breast Cancer Res,2011,13(2):206.
[30] Nevins JR,Potti A.Mining gene expression profiles:expression signatures as cancer phenotypes[J].Nat Rev Genet,2007,8(8):601-609.
[31] Kim MY,Oskarsson T,Acharyya S,et al.Tumor self-seeding by circulating cancer cells[J].Cell,2009,139(7):1315-1326.
[32] Comen E,Norton L,Massagué J.Clinical implications of cancer self-seeding[J].Nat Rev Clin Oncol,2011,8(6):369-377.
[33] Benito-Martin A,Di GA,Ceder S,et al.The new deal:a potential role for secreted vesicles in innate immunity and tumor progression[J].Front Immunol,2015,6:66.
[34] Kang Y,Siegel PM,Shu W,et al.A multigenic program mediating breast cancer metastasis to bone[J].Cancer Cell,2003,3(6):537-549.
[35] Huang Y,Song N,Ding Y,et al.Pulmonary vascular destabilization in the premetastatic phase facilitates lung metastasis[J].Cancer Res,2009,69(19):7529-7537.
[36] Minn AJ,Gupta GP,Siegel PM,et al.Genes that mediate breast cancer metastasis to lung[J].Nature,2005,436(7050):518-524.
[37] Steeg PS.Tumor metastasis:mechanistic insights and clinical challenges[J].Nat Med,2006,12(8):895-904.
[38] Lyle LT,Lockman PR,Adkins CE,et al.Alterations in pericyte subpopulations are associated with elevated blood-tumor barrier permeability in experimental brain metastasis of breast cancer[J].Clin Cancer Res,2016,22(21):5287-5299.
[39] Fong MY,Zhou W,Liu L,et al.Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis[J].Nat Cell Biol,2015,17(2):183-194.
[40] Bos PD,Zhang XH,Nadal C,et al.Genes that mediate breast cancer metastasis to the brain[J].Nature,2009,459(7249):1005-1009.
[41] Costa-Silva B,Aiello NM,Ocean AJ,et al.Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver[J].Nat Cell Biol,2015,17(6):816-826.
[42] Melo SA,Luecke LB,Kahlert C,et al.Glypican-1 identifies cancer exosomes and detects early pancreatic cancer[J].Nature,2015,523(7559):177-182.
[43] Tabariès S,Annis MG,Hsu BE,et al.Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis[J].Oncotarget,2015,6(11):9476-9487.